Statistical Methods for Immunogenicity Assessment
Harry Yang
Sold by THE SAINT BOOKSTORE, Southport, United Kingdom
AbeBooks Seller since 14 June 2006
New - Soft cover
Condition: New
Quantity: 1 available
Add to basketSold by THE SAINT BOOKSTORE, Southport, United Kingdom
AbeBooks Seller since 14 June 2006
Condition: New
Quantity: 1 available
Add to basketNew copy - Usually dispatched within 4 working days. 185.
Seller Inventory # B9780367737979
Develop Effective Immunogenicity Risk Mitigation Strategies
Immunogenicity assessment is a prerequisite for the successful development of biopharmaceuticals, including safety and efficacy evaluation. Using advanced statistical methods in the study design and analysis stages is therefore essential to immunogenicity risk assessment and mitigation strategies. Statistical Methods for Immunogenicity Assessment provides a single source of information on statistical concepts, principles, methods, and strategies for detection, quantification, assessment, and control of immunogenicity.
The book first gives an overview of the impact of immunogenicity on biopharmaceutical development, regulatory requirements, and statistical methods and strategies used for immunogenicity detection, quantification, and risk assessment and mitigation. It then covers anti-drug antibody (ADA) assay development, optimization, validation, and transfer as well as the analysis of cut point, a key assay performance parameter in ADA assay development and validation. The authors illustrate how to apply statistical modeling approaches to establish associations between ADA and clinical outcomes, predict immunogenicity risk, and develop risk mitigation strategies. They also present various strategies for immunogenicity risk control. The book concludes with an explanation of the computer codes and algorithms of the statistical methods.
A critical issue in the development of biologics, immunogenicity can cause early termination or limited use of the products if not managed well. This book shows how to use robust statistical methods for detecting, quantifying, assessing, and mitigating immunogenicity risk. It is an invaluable resource for anyone involved in immunogenicity risk assessment and control in both non-clinical and clinical biopharmaceutical development.
Harry Yang is a senior director, Jianchun Zhang is a principal statistician, Binbing Yu is an associate director, and Wei Zhao is a senior principal statistician at MedImmune, LLC in Gaithersburg, Maryland, USA.
"About this title" may belong to another edition of this title.
Please order through the Abebooks checkout. We only take orders through Abebooks - We don't take direct orders by email or phone.
Refunds or Returns: A full refund of the purchase price will be given if returned within 30 days in undamaged condition.
As a seller on abebooks we adhere to the terms explained at http://www.abebooks.co.uk/docs/HelpCentral/buyerIndex.shtml - if you require further assistance please email us at orders@thesaintbookstore.co.uk
Most orders usually ship within 1-3 business days, but some can take up to 7 days.
Order quantity | 1 to 6 business days | 1 to 6 business days |
---|---|---|
First item | £ 0.00 | £ 0.00 |
Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.